The case for Lockheed Martin’s Precision Strike Missile program rests on a $1.2 billion contract secured for the Increment 2 variant, yet the risk is that the production ramp required to meet future demand remains unproven. The company has locked in this funding following a successful second maritime test, reinforcing its position within the U.S. Army’s long-range precision strike portfolio. This development confirms the program’s technical viability but leaves the operational scale-up as the primary variable to watch.
The contract follows the completion of the second maritime test, a milestone that validates the system's performance in specific conditions. Lockheed Martin has designed the PrSM Increment 2 with a multimode seeker, a feature intended to engage both moving land and maritime targets. This capability distinguishes the Increment 2 from earlier versions and aligns with the Army’s broader strategic goals. Additional testing is already scheduled for 2027, indicating a continued focus on refining the weapon’s accuracy and reliability before full-scale deployment.
The read-through for investors and analysts is the company’s intention to quadruple its PrSM production capacity. Lockheed Martin has stated it plans to expand manufacturing significantly to meet future demand, a move that signals confidence in sustained orders beyond the current contract. This expansion is not a passive response to the recent award but an active effort to position the company for a larger market share. The ability to scale production efficiently will determine whether the company can capitalize on the growing demand for long-range precision strike capabilities in the current geopolitical environment.
The counterargument is that production capacity increases do not guarantee demand realization. While the U.S. Army has committed to the program, the actual pace of deliveries and the integration of these missiles into existing military infrastructure present logistical challenges. If the Army’s procurement timeline slows or if technical issues arise during the 2027 testing phase, the projected production increase could outpace actual orders. The risk is that the company commits resources to a capacity expansion that does not translate into immediate revenue growth, creating a mismatch between investment and return.
On balance, the $1.2 billion contract provides a solid foundation for Lockheed Martin’s PrSM business. The multimode seeker and successful maritime tests address key technical requirements, while the planned production quadrupling demonstrates strategic intent. The line to watch is the outcome of the 2027 tests and the actual pace of production ramp-up. If Lockheed Martin can deliver on its capacity expansion without significant delays, the program is poised to become a major contributor to the company’s defense portfolio. The facts support a positive outlook, but the execution of the production plan remains the decisive factor.